Canadian and US Drug Approval Times and Safety Considerations
Author:
Affiliation:
1. Nigel SB Rawson PhD, Senior Researcher, Center for Health Care Policy and Evaluation, Eden Prairie, MN
2. Kenneth I Kaitin PhD, Director, Tufts Center for the Study of Drug Development, Boston, MA
Publisher
SAGE Publications
Subject
Pharmacology (medical)
Link
http://journals.sagepub.com/doi/pdf/10.1345/aph.1D110
Reference29 articles.
1. The European Agency for the Evaluation of Medicinal Products’ Centralized Procedure for Product Approval: Current Status
2. Marketing Authorizations of Medicinal Products in the European Union: Past, Present, and Future
3. THE PRESCRIPTION DRUG USER FEE ACT OF 1992 AND THE NEW DRUG DEVELOPMENT PROCESS
4. Safety of FDA-Approved Drugs
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The timelines for the price and reimbursement authorization in Italy 2018–2020;Frontiers in Medicine;2022-12-21
2. Elephant in the Room;Circulation: Cardiovascular Quality and Outcomes;2018-01
3. Accès au marché précoce des médicaments : comparaison France/Canada de deux systèmes d’accès à des médicaments non approuvés pour des patients en impasse thérapeutique;Le Pharmacien Hospitalier et Clinicien;2016-12
4. Drug safety: withdrawn medications are only part of the picture;BMC Medicine;2016-02-13
5. Health Canada's use of priority review status for drugs for unmet needs;Regulatory Toxicology and Pharmacology;2015-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3